The burden of diabetes continues to escalate in North America, demanding effective, real-time solutions for blood glucose control. As a result, continuous glucose monitoring (CGM) systems have emerged as a vital tool, revolutionizing how patients and healthcare providers manage diabetes. The North America continuous glucose monitoring market was va